Logo Agilent Technologies

Agilent Technologies (A) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Agilent Technologies · Health Care · ref. ETF XLV · 73 calls · price $157.69
🏆JPI 2026 portfoliosSee tracking →
What the company does: Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries.

📈 Agilent Technologies (A) stock price

$157.69+26.2% over range
Aug 28, 25low $110.24 · high $159Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
82% recommend buying · 11 analysts
📊 JPI status : Agilent Technologies has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 A price target & analyst consensusprice $158

The price target · all analysts combined (10 targets)
Highest target · 1 firm of 10$175+11.0%
Median target · of 10 targets$155-1.7%
Lowest target · 1 firm of 10$148-6.1%
Current price$157.69
Where these 10 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 330% $160 ↔ $175
Below 770% $148 ↔ $156
Targets haven't kept up with the price. 82% of ratings say “Buy”, yet 7 of 10 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Morgan Stanley69% of its targets hit on this sector (825 calls tested). It aims for $175 (+11 %), call made on August 13, 2026, maturing on August 13, 2027 (15 d ago).

The 4 reliable analysts $153-3.3 %
The 6 other firms $156-1.4 %
How to read it: the 4 reliable firms are not filtered by optimism — 1 aim above the price, 3 below, hence their $153 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy982%
Hold218%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Agilent Technologies? The JPI assistant answers using our backtest data.

💰 Agilent Technologies dividend: yield, history & growth › open the full page

0.95%annual yield
That's ~$1.26 per share per year.

📈 Agilent Technologies fundamentals: valuation, margins & growth › open the full page

P/E 30.6Net margin 19.6 %Revenue growth +10.0 %Cheap for the growth

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 18 %
2023
Rev −0%Profit −1%
2024
Rev −5%Profit +4%
2025
Rev +7%Profit +1%

🔎 Detailed analyses

✅ Historical analyst reliability on A

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
ISI Group 100% +20.1% 4
Morgan Stanley  86% +10.4% 14
Goldman Sachs  78% +18.1% 9
Wells Fargo  75% +21.5% 16
Deutsche Bank  75% +8.9% 4
Jefferies  71% +14.3% 14
Cowen & Co. 71% +8.7% 7
Stifel  71% +8.5% 7
SVB Leerink 67% +17.1% 12
Barclays  67% +10.6% 18
See the other 11 firms
SVB Securities 29% -3.6% 7
Keybanc  29% -3.3% 7
BTIG  50% +10.1% 2
TD Cowen  55% +6.3% 11
UBS  56% +8.5% 9
Baird  59% +12.3% 22
B of A Securities  60% +3.4% 15
Evercore ISI Group  60% +11.6% 5
Credit Suisse 60% +12.6% 5
Citigroup  64% +9.7% 11
JP Morgan  67% +10.3% 12

📊 What $1,000 invested in Agilent Technologies would be worth › open the full page

In short — $1,000 invested in Agilent Technologies 10 years ago would be worth $3,177 today, i.e. +12%/yr on average. Best year: 2017 (+47%), worst: 2023 (-7%). Price performance, excluding dividends.

If I'd invested $1,000 in Agilent Technologies

InvestmentWorth todayGain
1 years ago$989-1%
3 years ago$888-11%
5 years ago$1,121+12%
→ See Agilent Technologies's full return history + gain calculator

Return by year (Agilent Technologies)

YearReturn$1,000 invested at year start
2026 (YTD)-2%$976 (-2%)
2025+1%$989 (-1%)
2024-3%$955 (-4%)
→ See Agilent Technologies's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Agilent Technologies

Loading news…

📋 All analyst calls on A

Morgan Stanley 
Aug 12, 26
▲ Overweight · 🎯$175
Price at call : $149.29 — upside +17%
Today : $157.69 — upside +11%
🎯 on A : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Aug 12, 27
▲ Outperform · 🎯$148
Price at call : $131.14 — upside +13%
Today : $157.69 — upside -6%
🎯 on A : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
Barclays 
Jun 24, 26
▲ Overweight · 🎯$150
Price at call : $135.51 — upside +11%
Today : $157.69 — upside -5%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jun 24, 27
Piper Sandler 
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$150
Price at call : $129.55 — gap to target +16%
Today : $157.69 — gap to target -5%
🎯 on A : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jun 11, 27
HSBC 
Jun 3, 26
▲ Buy · 🎯$165
Price at call : $138.37 — upside +19%
Today : $157.69 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Jun 3, 27
▲ Buy · 🎯$155
Price at call : $137.4 — upside +13%
Today : $157.69 — upside -2%
🎯 on A : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jun 2, 27
RBC Capital 
May 28, 26
▲ Outperform · 🎯$155
Price at call : $135.53 — upside +14%
Today : $157.69 — upside -2%
🎯 on A : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : May 28, 27
TD Cowen 
May 28, 26
▲ Buy · 🎯$155
Price at call : $135.53 — upside +14%
Today : $157.69 — upside -2%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : May 28, 27
See the other 65 calls, newest to oldest
Barclays 
May 28, 26
▲ Overweight · 🎯$145
Price at call : $135.53 — upside +7%
Today : $157.69 — upside -8%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 28, 27
Wells Fargo 
May 28, 26
▲ Overweight · 🎯$160
Price at call : $135.53 — upside +18%
Today : $157.69 — upside +1%
🎯 on A : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 28, 27
▲ Buy · 🎯$145
Price at call : $135.38 — upside +7%
Today : $157.69 — upside -8%
🎯 on A : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : May 28, 27
RBC Capital 
May 27, 26
▲ Outperform · 🎯$153
Price at call : $135.38 — upside +13%
Today : $157.69 — upside -3%
🎯 on A : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : May 27, 27
Baird 
May 26, 26
▲ Outperform · 🎯$156
Price at call : $115.08 — upside +36%
Today : $157.69 — upside -1%
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : May 26, 27
Keybanc 
Apr 28, 26
■ Sector Weight neutral · not a buy
🎯 on A : no call matured yet · 📊 on Health : 44.1% · -1.7% (143 calls)
in progress (365j)
matures : Apr 28, 27
Barclays 
Apr 14, 26
▲ Overweight · 🎯$140
Price at call : $119.77 — upside +17%
Today : $157.69 — upside -11%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 14, 27
TD Cowen 
Apr 13, 26
▲ Buy · 🎯$147
Price at call : $117.5 — upside +25%
Today : $157.69 — upside -7%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Apr 13, 27
▲ Outperform · 🎯$140
Price at call : $113.88 — upside +23%
Today : $157.69 — upside -11%
🎯 on A : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
▲ Overweight · 🎯$160
Price at call : $120.54 — upside +33%
Today : $157.69 — upside +1%
🎯 on A : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Mar 3, 27
UBS 
Feb 26, 26
▲ Buy · 🎯$165
Price at call : $121.38 — upside +36%
Today : $157.69 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 26, 27
TD Cowen 
Feb 26, 26
▲ Buy · 🎯$157
Price at call : $121.38 — upside +29%
Today : $157.69 — upside -0%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Feb 26, 27
Wells Fargo 
Feb 26, 26
▲ Overweight · 🎯$165
Price at call : $121.38 — upside +36%
Today : $157.69 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 26, 27
Barclays 
Feb 26, 26
▲ Overweight · 🎯$150
Price at call : $121.38 — upside +24%
Today : $157.69 — upside -5%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 26, 27
HSBC 
Jan 20, 26
▲ Buy · 🎯$180
Price at call : $135.83 — upside +33%
Today : $157.69 — upside +14%
🎯 on A : no call matured yet · 📊 on Health : 53.6% · +1.4% (28 calls)
in progress (365j)
matures : Jan 20, 27
▲ Outperform · 🎯$160
Price at call : $147.6 — upside +8%
Today : $157.69 — upside +1%
🎯 on A : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jan 5, 27
Barclays 
Dec 15, 25
▲ Overweight · 🎯$165
Price at call : $140.6 — upside +17%
Today : $157.69 — upside +5%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Dec 15, 26
Goldman Sachs 
Dec 9, 25
▲ Buy · 🎯$170
Price at call : $140.64 — upside +21%
Today : $157.69 — upside +8%
🎯 on A : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Dec 9, 26
▲ Overweight · 🎯$180
Price at call : $149.26 — upside +21%
Today : $157.69 — upside +14%
🎯 on A : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 2, 26
Citigroup 
Nov 25, 25
▲ Buy · 🎯$185
Price at call : $154.37 — upside +20%
Today : $157.69 — upside +17%
🎯 on A : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Nov 25, 26
UBS 
Nov 25, 25
▲ Buy · 🎯$180
Price at call : $154.37 — upside +17%
Today : $157.69 — upside +14%
🎯 on A : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Nov 25, 26
Wells Fargo 
Nov 25, 25
▲ Overweight · 🎯$175
Price at call : $154.37 — upside +13%
Today : $157.69 — upside +11%
🎯 on A : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 25, 26
JP Morgan 
Nov 25, 25
▲ Overweight · 🎯$180
Price at call : $154.37 — upside +17%
Today : $157.69 — upside +14%
🎯 on A : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 25, 26
Barclays 
Nov 25, 25
■ Equal-Weight neutral · not a buy · 🎯$165
Price at call : $154.37 — gap to target +7%
Today : $157.69 — gap to target +5%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Nov 25, 26
Baird 
Nov 25, 25
▲ Outperform · 🎯$165
Price at call : $157.2 — upside +5%
Today : $157.69 — upside +5%
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Nov 25, 26
■ Neutral neutral · not a buy · 🎯$165
Price at call : $157.2 — gap to target +5%
Today : $157.69 — gap to target +5%
🎯 on A : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Nov 25, 26
TD Cowen 
Oct 14, 25
▲ Buy · 🎯$162
Price at call : $138.04 — upside +17%
Today : $157.69 — upside +3%
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Oct 14, 26
JP Morgan 
Oct 9, 25
▲ Overweight · 🎯$165
Price at call : $140.11 — upside +18%
Today : $157.69 — upside +5%
🎯 on A : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Oct 9, 26
UBS 
Oct 8, 25
▲ Buy · 🎯$170
Price at call : $140.81 — upside +21%
Today : $157.69 — upside +8%
🎯 on A : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Oct 8, 26
▲ Buy · 🎯$165
Price at call : $140.81 — upside +17%
Today : $157.69 — upside +5%
🎯 on A : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 8, 26
■ In-Line neutral · not a buy · 🎯$140
Price at call : $140.81 — gap to target -1%
Today : $157.69 — gap to target -11%
🎯 on A : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 7, 26
Barclays 
Oct 2, 25
■ Equal-Weight neutral · not a buy · 🎯$145
Price at call : $141.64 — gap to target +2%
Today : $157.69 — gap to target -8%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 2, 26
Wells Fargo 
Sep 15, 25
▲ Overweight · 🎯$150
Price at call : $125.63 — upside +19%
Today : $157.69 — upside -5%
🎯 on A : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Sep 15, 26
Barclays 
Aug 29, 25
■ Equal-Weight neutral · not a buy · 🎯$125
Price at call : $125.21 — gap to target -0%
Today : $157.69 — gap to target -21%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Aug 29, 26
Baird 
Aug 28, 25
▲ Outperform · 🎯$142
Price at call : $125.66 — upside +13%
Today : $157.69 — upside -10%
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Aug 28, 26
Wells Fargo 
Aug 28, 25
▲ Overweight · 🎯$140
Price at call : $125.66 — upside +11%
Today : $157.69 — upside -11%
🎯 on A : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 28, 26
■ In-Line neutral · not a buy · 🎯$128
Price at call : $124.96 — gap to target +2%
Today : $157.69 — gap to target -19%
🎯 on A : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Aug 28, 26
■ In-Line neutral · not a buy · 🎯$130
Price at call : $121.01 — gap to target +7%
Today : $157.69 — gap to target -18%
🎯 on A : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 8, 26
■ In-Line neutral · not a buy · 🎯$125
Price at call : $118.62 — gap to target +5%
Today : $157.69 — gap to target -21%
🎯 on A : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jun 24, 26
Barclays 
Jun 24, 25
■ Equal-Weight neutral · not a buy · 🎯$125
Price at call : $118.62 — gap to target +5%
Today : $157.69 — gap to target -21%
🎯 on A : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jun 24, 26
UBS 
May 29, 25
■ Neutral neutral · not a buy · 🎯$130
Price at call : $111.92 — gap to target +16%
Today : $157.69 — gap to target -18%
🎯 on A : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 29, 26
JP Morgan 
May 29, 25
▲ Overweight · 🎯$155
Price at call : $111.92 — upside +38%
Today : $157.69 — upside -2%
Expected +38% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 100% (1 call matured) · 📊 on Health : 53.8% · +5.3% (355 calls)
+21.5%
stock +22% · XLV +11%
matured May 29, 26
Baird 
May 22, 25
▲ Outperform · 🎯$140
Price at call : $108.53 — upside +29%
Today : $157.69 — upside -11%
Expected +29% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+6.0%
stock +6% · XLV +14%
matured May 22, 26
Baird 
Feb 27, 25
▲ Outperform · 🎯$159
Price at call : $127.08 — upside +25%
Today : $157.69 — upside +1%
Expected +25% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-4.5%
stock -4% · XLV +9%
matured Feb 27, 26
TD Cowen 
Aug 22, 24
▲ Buy · 🎯$160
Price at call : $140.87 — upside +14%
Today : $157.69 — upside +1%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-15.4%
stock -15% · XLV -12%
matured Aug 22, 25
TD Cowen 
May 30, 24
▲ Buy · 🎯$153
Price at call : $130.41 — upside +17%
Today : $157.69 — upside -3%
Expected +17% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-14.8%
stock -15% · XLV -8%
matured May 30, 25
Baird 
May 30, 24
▲ Outperform · 🎯$136
Price at call : $131.42 — upside +3%
Today : $157.69 — upside -14%
Expected +3% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-14.8%
stock -15% · XLV -6%
matured May 30, 25
Baird 
Apr 22, 24
▲ Outperform · 🎯$147
Price at call : $139.2 — upside +6%
Today : $157.69 — upside -7%
Expected +6% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-24.6%
stock -25% · XLV -4%
matured Apr 22, 25
Baird 
Nov 21, 23
▲ Outperform · 🎯$130
Price at call : $123.92 — upside +5%
Today : $157.69 — upside -18%
Expected +5% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+3.8%
stock +4% · XLV +10%
matured Nov 20, 24
TD Cowen 
Aug 16, 23
▲ Outperform · 🎯$147
Price at call : $120.85 — upside +22%
Today : $157.69 — upside -7%
Expected +22% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+15.9%
stock +16% · XLV +15%
matured Aug 15, 24
Baird 
Aug 16, 23
▲ Outperform · 🎯$140
Price at call : $121.36 — upside +15%
Today : $157.69 — upside -11%
Expected +15% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+15.3%
stock +15% · XLV +14%
matured Aug 15, 24
TD Cowen 
May 24, 23
▲ Outperform · 🎯$145
Price at call : $120.99 — upside +20%
Today : $157.69 — upside -8%
Expected +20% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+24.4%
stock +24% · XLV +12%
matured May 23, 24
Baird 
May 24, 23
▲ Outperform · 🎯$144
Price at call : $120.99 — upside +19%
Today : $157.69 — upside -9%
Expected +19% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
+24.4%
stock +24% · XLV +12%
matured May 23, 24
Baird 
Mar 1, 23
▲ Outperform · 🎯$174
Price at call : $141.67 — upside +23%
Today : $157.69 — upside +10%
Expected +23% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-1.8%
stock -2% · XLV +15%
matured Feb 29, 24
TD Cowen 
Nov 22, 22
▲ Outperform · 🎯$168
Price at call : $155.35 — upside +8%
Today : $157.69 — upside +7%
Expected +8% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-18.5%
stock -18% · XLV -4%
matured Nov 22, 23
Baird 
Nov 22, 22
▲ Outperform · 🎯$170
Price at call : $155.35 — upside +9%
Today : $157.69 — upside +8%
Expected +9% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-18.5%
stock -18% · XLV -4%
matured Nov 22, 23
TD Cowen 
Aug 17, 22
▲ Outperform · 🎯$160
Price at call : $139.97 — upside +14%
Today : $157.69 — upside +1%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-14.8%
stock -15% · XLV +1%
matured Aug 17, 23
Baird 
Aug 17, 22
▲ Outperform · 🎯$160
Price at call : $142.29 — upside +12%
Today : $157.69 — upside +1%
Expected +12% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-15.1%
stock -15% · XLV +0%
matured Aug 17, 23
Baird 
May 25, 22
▲ Outperform · 🎯$161
Price at call : $120.38 — upside +34%
Today : $157.69 — upside +2%
Expected +34% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-0.7%
stock -1% · XLV -3%
matured May 25, 23
TD Cowen 
Feb 23, 22
▲ Outperform · 🎯$178
Price at call : $128.15 — upside +39%
Today : $157.69 — upside +13%
Expected +39% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+10.2%
stock +10% · XLV +1%
matured Feb 23, 23
TD Cowen 
Nov 23, 21
▲ Outperform · 🎯$187
Price at call : $152.97 — upside +22%
Today : $157.69 — upside +19%
Expected +22% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+2.6%
stock +3% · XLV +4%
matured Nov 23, 22
Baird 
Aug 18, 21
▲ Outperform · 🎯$170
Price at call : $163.02 — upside +4%
Today : $157.69 — upside +8%
Expected +4% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on A : 33% (12 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-14.1%
stock -14% · XLV -2%
matured Aug 18, 22
TD Cowen 
Jul 1, 21
▲ Outperform · 🎯$150
Price at call : $148.82 — upside +1%
Today : $157.69 — upside -5%
Expected +1% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
-19.0%
stock -19% · XLV +1%
matured Jul 1, 22
TD Cowen 
May 22, 20
▲ Outperform · 🎯$95
Price at call : $86.13 — upside +10%
Today : $157.69 — upside -40%
Expected +10% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+54.8%
stock +55% · XLV +25%
matured May 22, 21
TD Cowen 
Jan 6, 20
▲ Outperform · 🎯$95
Price at call : $85.08 — upside +12%
Today : $157.69 — upside -40%
Expected +12% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on A : 55% (11 calls matureds) · 📊 on Health : 49% · +1.0% (96 calls)
+44.4%
stock +44% · XLV +13%
matured Jan 5, 21

Frequently asked questions

Should I buy Agilent Technologies stock?

This isn't buy advice. For Agilent Technologies, the analyst consensus is "Buy", with an average price target of $155 (-2% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Agilent Technologies). We show the numbers — you decide.

Is it too late to buy Agilent Technologies? How high can it go?

The most bullish analyst target on Agilent Technologies is $175 (+11% above today's price); the average is $155. That's the upside they see. Check how reliable those analysts have actually been on Agilent Technologies on our site before trusting it.

Is Agilent Technologies still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 21 analysts have a real record on Agilent Technologies, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in Agilent Technologies? The case for and against

The arguments for and against, one by one, from the numbers: why invest in A (and why hesitate).

What has Agilent Technologies's past performance been?

Historical returns and a "how much if I had invested" calculator: A performance & returns.

Does Agilent Technologies pay a dividend?

Yield, consistency and growth history of the dividend: A's dividend.

What is the best month to buy A?

The 12 months ranked by the stock's past returns: best & worst month to buy A.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)